Health
Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy – OncoZine
Ficlatuzumab (AV-299) in combination with cytarabine (ara-C), demonstrates signs of clinical efficacy in patients with r/r AML….
Ficlatuzumab (formerly known as AV-299), a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity, in combination with cytarabine (also known as arabinofuranosyl…
Continue Reading
-
General23 hours agoTrump’s trade team chases 90 deals in 90 days
-
Noosa News17 hours agoTalented new artist on jazz scene
-
General24 hours agoGather Round’s first ever Sicko Saturday treats Adelaide Oval to a day of gloriously bad football
-
General23 hours agoClick-bait Bandt | The Spectator Australia